Logan Zemp

643 total citations
45 papers, 327 citations indexed

About

Logan Zemp is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Logan Zemp has authored 45 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Logan Zemp's work include Bladder and Urothelial Cancer Treatments (20 papers), Renal cell carcinoma treatment (12 papers) and Urinary and Genital Oncology Studies (11 papers). Logan Zemp is often cited by papers focused on Bladder and Urothelial Cancer Treatments (20 papers), Renal cell carcinoma treatment (12 papers) and Urinary and Genital Oncology Studies (11 papers). Logan Zemp collaborates with scholars based in United States, Canada and Ireland. Logan Zemp's co-authors include Steven M. Ornstein, Wade J. Sexton, Keith Rourke, Philippe E. Spiess, Scott M. Gilbert, Ali Hajiran, Roger Li, Ruth Jenkins, Jasreman Dhillon and Rohit Jain and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Logan Zemp

35 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Logan Zemp United States	12	149	112	80	61	56	45	327
Hiren V. Patel United States	11	114 0.8×	133 1.2×	94 1.2×	76 1.2×	35 0.6×	71	330
Danny Lascano United States	9	184 1.2×	61 0.5×	80 1.0×	59 1.0×	46 0.8×	30	403
Sultan Alkhateeb Saudi Arabia	10	268 1.8×	186 1.7×	95 1.2×	42 0.7×	56 1.0×	29	474
Anthony Polcari United States	13	195 1.3×	244 2.2×	71 0.9×	47 0.8×	40 0.7×	25	446
Stephen J. Bromage United Kingdom	10	104 0.7×	65 0.6×	46 0.6×	39 0.6×	50 0.9×	24	279
Stephan Degener Germany	10	164 1.1×	100 0.9×	38 0.5×	73 1.2×	78 1.4×	38	333
Jong Kil Nam South Korea	11	221 1.5×	239 2.1×	56 0.7×	82 1.3×	144 2.6×	50	483
José Daniel Subiela Spain	12	299 2.0×	171 1.5×	80 1.0×	38 0.6×	76 1.4×	60	501
Karl H. Tully Germany	10	156 1.0×	95 0.8×	96 1.2×	30 0.5×	40 0.7×	46	303
Jamie S. Pak United States	10	178 1.2×	66 0.6×	64 0.8×	26 0.4×	64 1.1×	25	325

Countries citing papers authored by Logan Zemp

Since Specialization

Citations

This map shows the geographic impact of Logan Zemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Logan Zemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Logan Zemp more than expected).

Fields of papers citing papers by Logan Zemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Logan Zemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Logan Zemp. The network helps show where Logan Zemp may publish in the future.

Co-authorship network of co-authors of Logan Zemp

This figure shows the co-authorship network connecting the top 25 collaborators of Logan Zemp. A scholar is included among the top collaborators of Logan Zemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Logan Zemp. Logan Zemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zemp, Logan, Peter A.S. Johnstone, G. Daniel Grass, et al.. (2025). NATURAL HISTORY AND MANAGEMENT OF PENILE CANCER PATIENTS AFTER ORGAN-SPARING SURGERY WITH PEIN POSITIVE MARGINS. Urologic Oncology Seminars and Original Investigations. 43(3). 104–104.

Chahoud, Jad, Marine Potez, Michael Carter, et al.. (2025). Optimizing clear cell renal cell carcinoma tumor-infiltrating lymphocytes under controlled hypoxic conditions.. Journal of Clinical Oncology. 43(5_suppl). 581–581.

Yu, Xiaoqing, Taylor Peak, Jasreman Dhillon, et al.. (2025). Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinoma. Scientific Reports. 15(1). 7703–7703. 3 indexed citations

Miller, Justin, Hongzhi Xu, Logan Zemp, et al.. (2025). OUTCOMES OF PATIENTS TREATED WITH ADDITIONAL BCG FOLLOWING A BCG UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER DIAGNOSIS. Urologic Oncology Seminars and Original Investigations. 43(3). 84–84. 1 indexed citations

Zemp, Logan, et al.. (2024). Management of Bulky Inguinal and Pelvic Lymph Nodes. Urologic Clinics of North America. 51(3). 335–345. 1 indexed citations

Gould, Billie, Prithvi Murthy, Kyle Rose, et al.. (2024). Tumor fraction and copy number burden from urinary cell-free tumor DNA (utDNA) to predict minimal residual disease prior to repeat-transurethral resection in high-risk non-muscle invasive bladder cancer (HR-NMIBC).. Journal of Clinical Oncology. 42(16_suppl). 4600–4600.

Li, Roger, Philippe E. Spiess, Wade J. Sexton, et al.. (2023). Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 41(16_suppl). e16613–e16613. 1 indexed citations

Li, Roger, Wenyi Fan, Kyle Rose, et al.. (2023). Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer. Urologic Oncology Seminars and Original Investigations. 41(11). 457.e17–457.e24. 1 indexed citations

Karam, José A., Viraj A. Master, Philippe E. Spiess, et al.. (2023). Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients. Urology. 182. 168–174. 2 indexed citations

10.

Abel, E. Jason, Viraj A. Master, Philippe E. Spiess, et al.. (2023). The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. European Urology Oncology. 7(2). 266–274. 16 indexed citations

11.

Shapiro, Daniel D., José A. Karam, Logan Zemp, et al.. (2023). Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. European Urology Open Science. 50. 43–46. 18 indexed citations

12.

Adashek, Jacob J., Yumeng Zhang, William Paul Skelton, et al.. (2021). Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?. Frontiers in Oncology. 10. 627025–627025. 6 indexed citations

13.

Chakiryan, Nicholas H., Da Jiang, Elizabeth Green, et al.. (2021). Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 40(3). 107.e11–107.e17. 1 indexed citations

14.

Aydın, Ahmet Murat, Richard R. Reich, Biwei Cao, et al.. (2021). Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy. Urologic Oncology Seminars and Original Investigations. 40(4). 164.e1–164.e7. 1 indexed citations

15.

Chakiryan, Nicholas H., Youngchul Kim, Ali Hajiran, et al.. (2021). Spatial clustering of CD68+ tumor associated macrophages with tumor cells is associated with worse overall survival in metastatic clear cell renal cell carcinoma. PLoS ONE. 16(4). e0245415–e0245415. 15 indexed citations

16.

Hajiran, Ali, et al.. (2020). Leveraging innovative therapies with an evolving understanding of the molecular pathogenesis of penile squamous cell carcinoma. Urologic Oncology Seminars and Original Investigations. 40(5). 173–178.

17.

Rourke, Keith, et al.. (2020). Improved artificial urinary sphincter outcomes using a transcorporal cuff placement in patients with a “fragile urethra”. Canadian Urological Association Journal. 14(12). E621–E624. 14 indexed citations

18.

Aydın, Ahmet Murat, et al.. (2020). Contemporary management of early stage testicular seminoma. Translational Andrology and Urology. 9(S1). S36–S44. 8 indexed citations

19.

Hajiran, Ali, et al.. (2020). Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity. Urologic Oncology Seminars and Original Investigations. 39(1). 72.e1–72.e5. 2 indexed citations

20.

Zemp, Logan, et al.. (2018). Contemporary management of renal trauma in Canada: A 10-year experience at a level 1 trauma centre. Canadian Urological Association Journal. 13(6). E177–E182. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact